Equities

Yifeng Pharmacy Chain Co Ltd

603939:SHH

Yifeng Pharmacy Chain Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (CNY)22.56
  • Today's Change-0.99 / -4.20%
  • Shares traded10.51m
  • 1 Year change-26.85%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4,0992,9682,079
Total Receivables, Net2,9072,5031,663
Total Inventory3,8083,6153,041
Prepaid expenses191270126
Other current assets, total1,1241,2231,007
Total current assets12,12910,5787,916
Property, plant & equipment, net5,6774,8954,513
Goodwill, net4,6114,1883,718
Intangibles, net474485396
Long term investments5933346.72
Note receivable - long term------
Other long term assets------
Total assets24,13721,03917,052
LIABILITIES
Accounts payable1,9561,6781,267
Accrued expenses556599389
Notes payable/short-term debt6,2155,0833,539
Current portion long-term debt/capital leases1,4581,278936
Other current liabilities, total1,0841,022615
Total current liabilities11,2699,6596,745
Total long term debt2,3392,1802,390
Total debt10,0138,5406,864
Deferred income tax27242.16
Minority interest643565383
Other liabilities, total545550
Total liabilities14,33212,4839,571
SHAREHOLDERS EQUITY
Common stock1,011722719
Additional paid-in capital3,8424,0773,988
Retained earnings (accumulated deficit)4,9733,8522,802
Treasury stock - common(42)(77)(28)
Unrealized gain (loss)21(17)--
Other equity, total------
Total equity9,8048,5567,481
Total liabilities & shareholders' equity24,13721,03917,052
Total common shares outstanding1,2101,2071,201
Treasury shares - common primary issue2.965.206.10
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.